Nephrotic Syndrome
- Jul 29, 2010
- Comments
- Viewed: 35126
Essentials of Diagnosis and General Considerations
- Edema
- Proteinuria >3.5 g/day
- Hypoalbuminemia <3 g/dL
- Hyperlipidemia: cholesterol >300 mg/100 mL
- Lipiduria: free fat, oval fat bodies, fatty casts
Because treatment and prognosis vary with the cause of nephrotic syndrome, renal biopsy is important. Light microscopy, electron microscopy, and immunofluorescence identification of immune mechanisms diagnose most causes of nephrosis.
Glomerular diseases associated with nephrosis include the following:
Minimal Glomerular Lesions
Minimal-change nephropathy (nil disease) accounts for about 20% of cases of nephrosis in adults and 90% in children. No abnormality is visible by examination of biopsy material with the light microscope. With the electron microscope, alterations of the GBM, with effacement of foot processes of the epithelial cells, are evident. There is no evidence of immune disease by immunofluorescence studies. The response to treatment with corticosteroids is good, but for patients who have frequent relapses with steroids or are steroid resistant, a course of cyclophosphamide or chlorambucil may induce a prolonged remission.
Patients who do not respond to these agents may show a favorable response with cyclosporine or tacrolimus. Renal function usually remains stable.
Focal Glomerulosclerosis
Focal glomerulosclerosis is the second most common cause of nephrotic syndrome in children and an increasing cause of the nephrotic syndrome in adults. The diagnosis is based on light microscope findings of segmental hyalinosis and sclerosis associated with effacement of the foot processes on electron microscopy. Focal glomerulosclerosis is frequently idiopathic but can be associated with human immunodeficiency virus infection and heroin use. A secondary form of focal glomerulosclerosis without the diffuse changes in foot processes may occur in patients with a solitary kidney, hyperfiltration syndromes, and reflux nephropathy. There are reports of familial variants. The response of the idiopathic form of focal glomerulosclerosis to therapy is suboptimal. Prolonged corticosteroid therapy produces remission in approximately 40% of patients.
Over a 10-year period, approximately 50% of patients will have chronic renal failure. Idiopathic focal glomerulosclerosis has a recurrence rate of 25% after transplantation.
Membranous Nephropathy
Examination of biopsy material with the light microscope shows thickening of the glomerular cells but no cellular proliferation. With the electron microscope, irregular lumpy deposits appear between the basement membrane and the epithelial cells, and new basement membrane material protrudes from the GBM as spikes or domes.
Immunofluorescence studies show diffuse granular deposits of Ig (especially IgG) and complement (C3 component). As the membrane thickens, glomeruli become sclerosed and hyalinized.
The pathogenesis of most cases of membranous nephropathy in humans is unclear. Several mechanisms have been suggested. They include trapping of circulating immune complexes or binding of an antibody to scattered glomerular antigens (either present already or “planted” after a nonrenal-source antigen lodges in the glomerulus).
There is considerable controversy regarding the effectiveness of therapy with steroids or immunosuppressive agents. Therapy should be most often used in patients at high risk of progressive renal failure with the following criteria: proteinuria >5 g/day, hypertension, and elevated serum creatinine.
Also in this section
- New PSA test examines protein structures to detect prostate cancers
- A better way to image metastatic prostate cancer
- Newly discovered protein may protect kidney cells from injury
- A person’s diet, acidity of urine may affect susceptibility to UTIs
- Award-winning agent developed for prostate cancer diagnosis and treatment
- New treatment for polycystic kidney disease
- Kidney failure impacts survival of sepsis patients
- Urine-based test improves on PSA for detecting prostate cancer
- Unemployment linked to rise in prostate cancer deaths
- Advanced viral gene therapy eradicates prostate cancer in preclinical experiments
- Recurrence of prostate cancer detected earlier with innovative PSMA-ligand PET/CT
- Treating gum disease reduces prostate symptoms, CWRU researchers find
Post a comment
[ + Comment here + ]
There are no comments for this entry yet. [ + Comment here + ]
Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.